How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

NP

OOTC:NPTX
Get a brief AI stock analysisSaves ~ 15 minutes of your time

NP

Neuropathix IncOOTC NPTX Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

OOTC - OTC

FAIR VALUE

Is NPTX undervalued compared to its fair value?

The fair value of NPTX stock is hidden USD. Relative to the market price of 0 USD Neuropathix Inc is hidden.

Neuropathix, Inc. is a biopharmaceutical company. The company is headquartered in Doylestown, Pennsylvania and currently employs 6 full-time employees. The company went IPO on 2016-09-12. The company is focused on discov...[More about valuation]

Neuropathix Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0 $B

Price:

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.017

FINANCIALS

Neuropathix financial for reporting period

Income Statement

0.0002 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0004 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0016 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0.0002 B 100%
-0.0004 B -176%
-0.0016 B -767%

Balance Sheet

0.0004 B
-0.0053 B

0.0019 B

Financial Position Analysis

Assets

0.0004 B
Current Assets
0.0001 B
Total non-current assets
0.0003 B

Total current liabilities
0.0036 B
Total non-current liabilities
0.002 B

Cash Flow Statement

0 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0001 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Neuropathix fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-1659 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is NPTX attractive for investment based on fundamental analysis?

NPTX stock rating is hidden. Neuropathix is a hidden by Eyestock methodology.

Get NPTX Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

-1 064

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

0.031

Debt / Equity ratio:

ROE:

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

NPTX analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for NPTX to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Neuropathix Inc competitors

LL

LLY

Eli Lilly and Co

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The company is headquartered in Indianapolis, Indiana and currently employs ...

Discover

NO

NOVO B.CO

Novo Nordisk A/S

Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. The firm is also engaged i...

Discover

JN

JNJ

Johnson & Johnson

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. The company is headquartered in Ne...

Discover

Neuropathix Inc dividends

NPTX dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About NPTX stock

About the company Neuropathix Inc

Market cap $B

0

Dividend yield

Shares outstanding

93.8106 B

Neuropathix, Inc. is a biopharmaceutical company. The company is headquartered in Doylestown, Pennsylvania and currently employs 6 full-time employees. The company went IPO on 2016-09-12. The company is focused on discovering, developing, and commercializing novel therapeutics from its proprietary synthetic cannabinoid derivatives platform potentially useful for a range of inflammatory and neuropathic pain-related diseases. The firm's product candidate includes KLS-13019 and KLS-13023. KLS-13019 can control mechanical sensitivity and inflammation associated with Chemotherapy-induced peripheral neuropathy (CIPN) in the absence of tolerance development, and also reduce opioid craving behavior. KLS-13023 is a drug candidate that includes synthetic cannabidiol (CBD) formulated in a gel capsule designed for potential use in humans. Its Drug discovery platform potentially treats neurological and oxidative stress-related disorders, such as overt hepatic encephalopathy (OHE), Chronic Traumatic Encephalopathy (CTE) and CIPN with current good manufacturing practices (cGMP) pharmaceutical grade semi-synthetic and synthetic cannabinoids.

NPTX profile

  • Ticker

    NPTX

  • Country

    USA

  • Exchange

    OOTC - OTC

  • Report currency

    USD - US dollar

  • IPO date

    12 September 2016

  • Sector

    Healthсare

  • Industry

    Pharmaceuticals

  • Employees

    6

  • City

    Doylestown

  • Address

    3805 Old Easton Rd

  • Cusip

    64132Q109